• Home
  • ABOUT
    • Management Team
    • Advisory Board
    • Corporate Highlight Deck
    • About Us
  • Science
    • Corporate Highlight Deck
    • TBI Data Highlights
    • Stroke Data
    • Alzheimer's Data Summary
  • Resources
    • Download Resources
  • Contact
  • More
    • Home
    • ABOUT
      • Management Team
      • Advisory Board
      • Corporate Highlight Deck
      • About Us
    • Science
      • Corporate Highlight Deck
      • TBI Data Highlights
      • Stroke Data
      • Alzheimer's Data Summary
    • Resources
      • Download Resources
    • Contact
  • Sign In
  • Create Account
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • ABOUT
    • Management Team
    • Advisory Board
    • Corporate Highlight Deck
    • About Us
  • Science
    • Corporate Highlight Deck
    • TBI Data Highlights
    • Stroke Data
    • Alzheimer's Data Summary
  • Resources
    • Download Resources
  • Contact

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

Stroke Data Highlights

15.5x Zoom of hemorrhage incidences between tPA+PBS and tPA+LG3

LG3: Demonstrates Efficacy in Acute Stroke and tPA-induced Hemorrhage

  • Highly efficacious neuroprotection with single dose
  • Directly homes to site of injury
  • Reduces mortality & brain damage preclinically
  • Improves tPA (tissue plasminogen activator) safety by reducing hemorrhage risk
  • Compatible with commonly prescribed medications

Additional Information

Post-Stroke Day 3 Infarct Volume

Stroke & Stroke+LG3 examples

Copyright © 2026 Stream Biomedical Inc. - All Rights Reserved.

  • Home
  • TBI Data Highlights
  • Stroke Data
  • Alzheimer's Data Summary
  • What is LG3?
  • Contact

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept